Metoprolol's effectiveness and safety are influenced by genetic variations in the CYP2D6 gene affecting its metabolism and polymorphisms in the ADRB1 gene altering receptor sensitivity. These genetic differences impact metoprolol's plasma levels and its therapeutic efficacy in controlling heart rate and arrhythmias, underscoring the need for tailored drug dosing.